Hoth Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Robb Knie
Chief executive officer
US$868.8k
Total compensation
CEO salary percentage | 51.8% |
CEO tenure | 7yrs |
CEO ownership | 0.7% |
Management average tenure | 5.2yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Hoth Therapeutics partners with Altasciences to manufacture HT-TBI for brain injury
Sep 20Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule
Jun 29Here's Why We're Watching Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Situation
Nov 12Hoth Therapeutics extends agreement for experimental antibiotic
Jun 18We're Not Very Worried About Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Rate
Jun 10Hoth Therapeutics expands research agreement with VCU for COVID-19 therapeutic
May 05Hoth Therapeutics shares rise 10% on developmental plans for HT-KIT in multiple orphan diseases and rare cancers
May 03Hoth provides pipeline and regulatory timeline update
Feb 02FDA grants Hoth Therapeutics Pre-IND meeting for HT-001, shares up 15%
Jan 13Hoth Therapeutics to initiate IND enabling studies of HT-001 in cancer
Jan 11Hoth Therapeutics inks deal for treatment of multi-drug resistant bacterial lung infections, shares up 15%
Jan 04Hoth therapeutics signs production agreement for HT-001, Shares up 75%
Dec 31Companies Like Hoth Therapeutics (NASDAQ:HOTH) Could Be Quite Risky
Dec 02Hoth Therapeutics shows encouraging preclinical action in autoimmune skin disorder
Nov 03CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$869k | US$450k | -US$8m |
Sep 30 2023 | n/a | n/a | -US$10m |
Jun 30 2023 | n/a | n/a | -US$10m |
Mar 31 2023 | n/a | n/a | -US$11m |
Dec 31 2022 | US$1m | US$450k | -US$11m |
Sep 30 2022 | n/a | n/a | -US$11m |
Jun 30 2022 | n/a | n/a | -US$12m |
Mar 31 2022 | n/a | n/a | -US$13m |
Dec 31 2021 | US$1m | US$400k | -US$14m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$10m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$781k | US$350k | -US$7m |
Sep 30 2020 | n/a | n/a | -US$10m |
Jun 30 2020 | n/a | n/a | -US$10m |
Mar 31 2020 | n/a | n/a | -US$9m |
Dec 31 2019 | US$2m | US$350k | -US$8m |
Sep 30 2019 | n/a | n/a | -US$4m |
Jun 30 2019 | n/a | n/a | -US$3m |
Mar 31 2019 | n/a | n/a | -US$3m |
Dec 31 2018 | US$308k | US$250k | -US$2m |
Sep 30 2018 | n/a | n/a | -US$3m |
Dec 31 2017 | US$146k | US$146k | -US$3m |
Compensation vs Market: Robb's total compensation ($USD868.82K) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Robb's compensation has been consistent with company performance over the past year.
CEO
Robb Knie (54 yo)
7yrs
Tenure
US$868,823
Compensation
Mr. Robb Knie served as the Chief Executive Officer, Chief Financial Officer and Chairman of the Board of Directors of FoxWayne Enterprises Acquisition Corp. (Nasdaq: FOXW) since October 15, 2020 until Jan...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7yrs | US$868.82k | 0.68% $ 40.3k | |
Chief Financial Officer | 5.2yrs | no data | no data | |
Executive Vice President of Operations | 2yrs | no data | no data |
5.2yrs
Average Tenure
Experienced Management: HOTH's management team is seasoned and experienced (5.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7yrs | US$868.82k | 0.68% $ 40.3k | |
Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
Member of the Scientific Advisory Board | 3.3yrs | no data | no data | |
Independent Director | 5.8yrs | US$65.21k | 0% $ 0 | |
Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
Independent Director | 4.1yrs | US$65.21k | 0.0027% $ 162.8 | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Independent Director | 4.3yrs | US$65.21k | 0.026% $ 1.5k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.4yrs | US$65.21k | 0.77% $ 45.7k | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data |
4.3yrs
Average Tenure
55yo
Average Age
Experienced Board: HOTH's board of directors are considered experienced (4.3 years average tenure).